Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fulcrum Therapeutics (FULC) Asset Utilization Ratio (2020 - 2025)

Fulcrum Therapeutics (FULC) has 6 years of Asset Utilization Ratio data on record, last reported at 0.34 in Q2 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 9.51% to 0.34 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.34, a 9.51% increase, with the full-year FY2024 number at 0.31, up 2564.82% from a year prior.
  • Asset Utilization Ratio reached 0.34 in Q2 2025 per FULC's latest filing, up from 0.3 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for FULC hit a ceiling of 0.34 in Q2 2025 and a floor of 0.01 in Q3 2023.
  • A 5-year average of 0.11 and a median of 0.07 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 85.94% in 2023, then skyrocketed 3064.27% in 2024.
  • Tracing FULC's Asset Utilization Ratio over 5 years: stood at 0.08 in 2021, then tumbled by 65.79% to 0.03 in 2022, then plummeted by 60.89% to 0.01 in 2023, then soared by 2735.39% to 0.3 in 2024, then rose by 14.47% to 0.34 in 2025.
  • Business Quant data shows Asset Utilization Ratio for FULC at 0.34 in Q2 2025, 0.3 in Q4 2024, and 0.28 in Q3 2024.